Resources Contact Us Home
Antibodies specific for soluble amyloid beta peptide protofibrils and uses thereof

Image Number 14 for United States Patent #8106164.

The invention pertains to the development of antibodies that specifically bind amyloid beta protein (Abeta) in its protofibril conformation. The invention also comprises methods of using anti-Abeta protofibril antibodies to diagnose or treat Alzheimer's disease, Down's syndrome Lewybody dementia, vascular dementia, and other neurodegenerative disorders. Furthermore, the invention pertains to the use of anti-Abeta protofibril antibodies to screen and identify substances that will modulate protofibril activity or formation in vitro or in vivo. The invention also pertains to methods for synthesising pure Abeta protofibril antigens as well as to a method for stabilising Abeta protofibrils antigens as well as to a method for stabilising Abeta protofibrils.

  Recently Added Patents
High performance actuator motor
Method and apparatus for wireless transmission of diagnostic information
Antagonists of the glucagon receptor
Delay lines, amplifier systems, transconductance compensating systems and methods of compensating
Systems, methods, and apparatus to prepare a mobile device for provisioning
Recording medium, playback device, integrated circuit
Image forming apparatus and information processing apparatus
  Randomly Featured Patents
Solvent disperser for removing oil from sponge core
Interleaved hardware multithreading processor architecture
Multilayer metal fiber yarn
Blade platform cooling
Adjustable pallet protector assembly for a single pallet or an array of pallets
System and methods for accelerated data storage and retrieval
Anti-herpes virus and cytomegalovirus polyester oligomers
Epoxide inhibitors of cysteine proteases
Method of playing a card game
System and method for local pulmonary structure classification for computer-aided nodule detection